VY-NPC101: in vitro and in vivo validation of a novel AAV gene replacement therapy to treat Niemann-Pick disease Type C1

被引：0
|
作者：
Knoll, E. [1 ]
Ezell, B. [1 ]
Liu, E. [1 ]
Sayed-Zahid, A. [1 ]
Li, M. [1 ]
Patzke, H. [1 ]
Tocci, J. [1 ]
Brown, J. [1 ]
Bales, K. [1 ]
Yonutas, H. M. [1 ]
机构：
[1] Voyager Therapeut, Cambridge, MA USA
来源：
HUMAN GENE THERAPY | 2021年 / 32卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P071
引用
收藏
页码：A50 / A50
页数：1
相关论文
共 50 条
  • [1] Characterization of a Novel AAV Gene Replacement Therapy, VY-NPC101, In Vitro and In Vivo for the Treatment of Niemann-Pick Disease Type C1
    Knoll, Elisabeth R.
    Tocci, Jenna
    Ezell, Brian
    Liu, Eric
    Sayed-Zahid, Ambreen
    Li, Mingwei
    Patzke, Holger
    Carter, Todd
    Bales, Kelly
    Brown, Jeffrey
    Yonutas, Heather
    MOLECULAR THERAPY, 2022, 30 (04) : 436 - 436
  • [2] A Novel Small NPC1 Promoter Enhances AAV-Mediated Gene Therapy in Mouse Models of Niemann-Pick Type C1 Disease
    Hughes, Michael Paul
    Nelvagal, Hemanth Ramesh
    Coombe-Tennant, Oliver
    Smith, Dave
    Smith, Claire
    Massaro, Giulia
    Poupon-Bejuit, Laura
    Platt, Frances Mary
    Rahim, Ahad Abdul
    CELLS, 2023, 12 (12)
  • [3] Adeno-Associated Viral Gene Therapy To Treat Niemann-Pick Disease, Type C1
    Chandler, Randy J.
    Williams, Ian M.
    Incao, Arturo A.
    Porter, Forbes D.
    Pavan, William J.
    Venditti, Charles P.
    MOLECULAR THERAPY, 2015, 23 : S79 - S79
  • [4] Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1
    Kurokawa, Yoshie
    Osaka, Hitoshi
    Kouga, Takeshi
    Jimbo, Eriko
    Muramatsu, Kazuhiro
    Nakamura, Sachie
    Takayanagi, Yuki
    Onaka, Tatsushi
    Muramatsu, Shin-ichi
    Yamagata, Takanori
    HUMAN GENE THERAPY, 2021, 32 (11-12) : 589 - 598
  • [5] Gene Therapy Moves Forward for Niemann-Pick Disease Type C1
    McIvor, R. Scott
    HUMAN GENE THERAPY, 2021, 32 (11-12) : 540 - 540
  • [6] Peripheral and Behavioral Impacts of AAV Gene Therapy in a Mouse Model of Niemann-Pick Disease, Type C1
    Epstein, Benjamin E.
    Soden, Gabrielle M.
    Incao, Arturo A.
    Pavan, William J.
    MOLECULAR THERAPY, 2024, 32 (04) : 734 - 735
  • [7] Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice
    Davidson, Cristin D.
    Gibson, Alana L.
    Gu, Tansy
    Baxter, Laura L.
    Deverman, Benjamin E.
    Beadle, Keith
    Incao, Arturo A.
    Rodriguez-Gil, Jorge L.
    Fujiwara, Hideji
    Jiang, Xuntian
    Chandler, Randy J.
    Ory, Daniel S.
    Gradinaru, Viviana
    Venditti, Charles P.
    Pavan, William J.
    LIFE SCIENCE ALLIANCE, 2021, 4 (10)
  • [8] Olfactory Deficits in Niemann-Pick Type C1 (NPC1) Disease
    Hovakimyan, Marina
    Meyer, Anja
    Lukas, Jan
    Luo, Jiankai
    Gudziol, Volker
    Hummel, Thomas
    Rolfs, Arndt
    Wree, Andreas
    Witt, Martin
    PLOS ONE, 2013, 8 (12):
  • [9] Gene therapy for the treatment of Niemann-Pick disease type C1: Comparison of AAV9 to a novel serotype, AAV-PHP.B
    Davidson, Cristin
    Gibson, Alana
    Gu, Tansy
    Chandler, Randy
    Deverman, Benjamin
    Gradinaru, Viviana
    Venditti, Charles
    Pavan, William
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S36 - S37
  • [10] Optimization of Systemic AAV9 Gene Therapy in Niemann-Pick Type C1 Mice
    Mylvara, Avani
    Davidson, Cristin
    Gu, Tansy
    Gibson, Alana L.
    Baxter, Laura
    Incao, Art
    Venditti, Charles P.
    Pavan, William
    Porter, Forbes D.
    MOLECULAR THERAPY, 2024, 32 (04) : 732 - 732
12345